SCHEMBL20107681

SCHEMBL20107681

O=C(O)c1cc(F)c(Br)cc1OCC(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 6/20 0.43
RXRA P19793 1/20 0.42
HNF4A P41235 1/20 0.42
PYGL P06737 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
KCNK2 O95069 1/20 0.40
KCNK10 P57789 1/20 0.40
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20107631 0.88 KDM4E (0.45) KDM4EHSD17B10ALDH1A1RXRAHNF4A
SCHEMBL1487907 0.85 KDM4E (0.51) KDM4EHSD17B10TSHRALDH1A1RXRA
SCHEMBL20107970 0.79 KDM4E (0.49) KDM4EALDH1A1CYP1A2CYP2C9POLB
SCHEMBL7348455 0.79 ALDH1A1 (0.43) KDM4EHSD17B10ALDH1A1RXRAHNF4A
SCHEMBL20107595 0.78 KDM4E (0.50) KDM4EHSD17B10ALDH1A1RXRAHNF4A
SCHEMBL19684853 0.78 TSHR (0.51) KDM4EHSD17B10TSHRLCKFYN
SCHEMBL1965983 0.78 ALDH1A1 (0.53) KDM4EHSD17B10ALDH1A1RXRAHNF4A
SCHEMBL20107888 0.76 DHODH (0.47) KDM4EPYGLNPSR1MEN1MAPT
SCHEMBL5612784 0.76 KDM4E (0.55) KDM4EALDH1A1RXRAHNF4ACYP1A2
SCHEMBL20521864 0.76 KDM4E (0.51) KDM4EALDH1A1RXRAHNF4ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3532468-B1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AG (DE) 2022-03-23 EP disclosed
WO-2019197269-A1 COMBINATIONS OF COPANLISIB WITH TRIAZOLONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2019-10-17 WO disclosed
EP-3553052-A1 5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL DERIVATIVES FOR THE TREATMENT OF CANCER Bayer AG (DE) 2019-10-16 EP disclosed
WO-2018077923-A1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed
WO-2018077944-A2 4,5-ANNULATED 1,2,4-TRIAZOLONES BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed